Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

HLA-DRα1 Constructs Block CD74 Expression and MIF Effects in Experimental Autoimmune Encephalomyelitis.
FDA denies Teva Copaxone generic trials petition
Nephrotic syndrome in multiple sclerosis patients who had undergone long-term interferon β-1b therapy.
Biogen Idec and Abbott Announce Positive Top-Line Results from the First Registrational Trial for Daclizumab HYP in relapsing-Remitting Multiple Sclerosis
Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Nephritis
Monomethyl fumarate promotes Nrf2-dependent neuroprotection in retinal ischemia-reperfusion.
Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder Patients in Turkish Cohort: Demographic, Clinical, and Laboratory Features.
Teriflunomide, an immunomodulatory drug, exerts anticancer activity in triple negative breast cancer cells.
Evidence for the efficacy of interferon beta-1b in delaying the onset of clinically definite multiple sclerosis in individuals with clinically isolated syndrome.
Discontinuation of Disease-Modifying Treatment for Multiple Sclerosis
Selective inhibition of CCR7- TEM cells activation by a novel peptide targeting Kv1.3 in a rat EAE model.
Adeona and the Skirball Foundation Join Forces to Advance Multiple Sclerosis Research
Rituximab in paediatric onset multiple sclerosis: a case series.
Receptos initiates clinical trials for S1P1 agonist program, aimed at multiple sclerosis
Santhera Announces Successful Outcome of Phase III Study with Catena®/Raxone® in Duchenne Muscular Dystrophy
Imovane: Best Online Pharmacy
Increased Serum Brain-derived Neurotrophic Factor in Multiple Sclerosis Patients on Interferon-β and Its Impact on Functional Abilities.
Cladribine
A meta-analysis of whole genome linkage screens in multiple sclerosis.
Disability outcome measures in multiple sclerosis clinical trials: current status and future prospects.
Restoration of axon conduction and motor deficits by therapeutic treatment with glatiramer acetate.
Management of Fulminant Multiple Sclerosis With Rituximab: A Case Report.
Clinical relevance of differential lymphocyte recovery after alemtuzumab therapy for multiple sclerosis.
Long-term daclizumab therapy in relapsing-remitting multiple sclerosis.
Oral Laquinimod for Multiple Sclerosis Granted Fast Track Status by FDA

Pages